Connect with us
The Spanish biotechnology sector, detailed in the AseBio 2023 Report, generated over €16.6 billion in 2022, 1.5% of GDP, and contributed 162,845 jobs. Private financing reached...
Neuraxpharm aims for €500 million in net sales in 2024, up 13.6% from €440 million last year, driven by its focus on CNS disorder treatments. Acquisitions,...
Emerging technologies are pivotal in healthcare. GSK's María Cardenal-Iradier, Jorge Pou, and Sergio Ostalé presented to the IDIS Foundation's Innovation Committee their proposals using AI to...
LEO Pharma, specializing in medical dermatology and thrombosis, saw a 7% revenue increase in 2023, reaching €1.54 billion in net sales. In Spain, growth was 6.9%,...
Grifols increased its private bond issue by €300 million, totaling €1.3 billion. The bonds, maturing in May 2030 with a 7.5% annual coupon, will repay part...
The Biomechanics Institute (IBV) achieved 12.4 million euros in 2023, a 20% increase from the previous year, with 334 projects and 1,100 technological solutions developed for...
MicThera, a biotech startup from Lodi specializing in bacterial-inspired prostate cancer therapies, secured a €1 million investment from Indaco Bio Fund. The funds will develop new...
Tetra Pharm Technologies and Kvantify, both Copenhagen-based companies, are partnering to revolutionize drug discovery targeting the endocannabinoid system (ECS). This alliance aims to accelerate drug development,...
Oryzon Genomics shares rose nearly 3% after announcing its participation in the European Med4Cure project. Med4Cure, funded with €1 billion in public financing, aims to attract...
Vytrus Biotech raised €2.3 million through a capital round and share sales, led by Boyser and minority shareholders. The funds will support expansion and new technologies....
 |
|
 |  |
 |
|